Answers are grounded in this paper and cite their sources.
Case Reports1 May 1962Cardiac Failure Simulating Viral HepatitisThree Cases with Serum Transaminase Levels above 1,000ROBERT G. LOGAN, M.D., FRANK M. MOWRY, M.D., RICHARD D. JUDGE, M.D.ROBERT G. LOGAN, M.D., FRANK M. MOWRY, M.D., RICHARD D. JUDGE, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-56-5-784 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptCardiac failure is a recognized cause of hepatic dysfunction. Three cases of congestive failure due primarily to aortic stenosis have recently come to our attention, each of which manifested striking clinical and laboratory evidence of hepatic necrosis. The serum levels of glutamic-oxalacetic transaminase in each instance exceeded 1,000 units. In two of these cases a clinical diagnosis of viral hepatitis was made antemortem, but autopsy in all three showed only centrilobular necrosis of the liver.CASE REPORTSCASE 1A 27-year-old white male was admitted to the University of Michigan Medical Center for the third time on February 2, 1961....References1. KARMENWRÓBLEWSKILADUE AFJS: Transaminase activity in human blood. J. Clin. Invest. 34: 126, 1955. CrossrefMedlineGoogle Scholar2. AGRESSKIM CMJH: Evaluation of enzymatic testing in the diagnosis of heart disease. Amer. J. Cardiol. 6: 641, 1960. CrossrefMedlineGoogle Scholar3. AGRESS CM: Evaluation of the transaminase test. Amer. J. Cardiol. 3: 74, 1959. CrossrefMedlineGoogle Scholar4. WRÓBLEWSKI F: The clinical significance of alterations in transaminase activities of serum and other body fluids. Advance Clin. Chem. 1: 313, 1958. CrossrefMedlineGoogle Scholar5. WRÓBLEWSKI F: The clinical significance of transaminase activities of serum. Amer. J. Med. 27: 911, 1959. CrossrefMedlineGoogle Scholar6. LEIBERMANLASKYDULKINLOBSTEIN JIISIOE: Serum glutamic oxalacetic transaminase activity in conditions associated with myocardial infarction. I. Bodily trauma. II. Cerebral vascular accidents and congestive heart failure. Ann. Intern. Med. 46: 485, 497, 1957. LinkGoogle Scholar7. CHINSKYSCHMAGRANOFFSHERRY MGLS: Serum transaminase activity; observations in a large group of patients. J. Lab. Clin. Med. 47: 108, 1956. MedlineGoogle Scholar8. SHIELDSSHANNON LHRE: Acute hepatic congestion as a factor in elevated serum glutamic oxaloacetic transaminase titers above 400 units. Amer. J. Med. Sci. 326: 438, 1958. CrossrefGoogle Scholar9. KILLIPPAYNE TMA: High serum transaminase activity in heart disease. Circulation 21: 646, 1960. CrossrefMedlineGoogle Scholar10. FRAGGEKOPELIGLAUER RGFBA: Serum glutamic oxalacetic transaminase in congestive heart failure: clinical study and review of the literature. Ann. Intern. Med. 52: 1042, 1960. LinkGoogle Scholar11. RICHMANDELMANGROB SMAJD: Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Amer. J. Med. 30: 211, 1961. CrossrefMedlineGoogle Scholar12. ZELMANWANGAPPELHANZ SCCI: Transaminase in serum and liver correlated with liver cell necrosis in needle aspiration biopsies. Amer. J. Med. Sci. 237: 323, 1959. CrossrefMedlineGoogle Scholar13. BANGIVERSONJAGTTOBIASSEN NJKTG: Serum glutamic-oxaloacetic transaminase activity as an index of centrilobular liver cell necrosis. Amer. J. Med. 11: 170, 1951. MedlineGoogle Scholar14. ELLENBERGOSSERMAN MKE: The role of shock in the production of central liver cell necrosis. Amer. J. Med. 11: 170, 1951. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ROBERT G. LOGAN, M.D.; FRANK M. MOWRY, M.D.; RICHARD D. JUDGE, M.D.Affiliations: Ann Arbor, MichiganFrom the Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan.Requests for reprints should be addressed to Dr. Robert G. Logan, M.D., Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPassive liver congestion and hypoxic hepatitisModified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart TransplantationRisk Factors for Liver Injury with an Elevated Serum Bilirubin Concentration Caused by Antituberculous DrugsThe Liver in Systemic IllnessCardiovascular Diseases and the LiverThe Involvement of the Liver in Systemic DiseasesSystemic Disease and the LiverYou've gotta have heart!The liver in heart failureMultiorgan Failure After Cardiac Arrest in a 20-Year-Old ManPathogenesis of centrilobular necrosis following congestion of the liverBile Salts, Bile Flow, and CholestasisLiver Dysfunction in Critical IllnessCardiogenic Hepatorenal SyndromeJaundice in systemic diseaseThe role of hepatic venous congestion and endotoxaemia in the production of fulminant hepatic failure secondary to congestive heart failureSevere Cardiomyopathy Simulating Hepatitis in AdolescenceDiffuse hepatic calcification as a sequela to shock liverISCHEMIC HEPATITIS: CLINICAL FEATURES, DIAGNOSIS AND PROGNOSISMarkedly increased serum aspartate aminotransferase activity in congestive heart failureInterpretation of blood chemistries, part 2Die Schockleber: Eine retrospektive klinische StudieFulminant hepatic failure due to transient circulatory failure in patients with chronic heart diseaseChemical Profiles of DiseaseLeft-sided heart failure presenting as hepatitisThe liver when the heart failsThe Laboratory in the Diagnosis and Management of Viral HepatitisChemical profiles of diseaseCase 15-1972The Liver in Congestive Heart FailureIntestinal Infarction Without Mesenteric Vascular Occlusion A Report of 31 CasesBYRON U. MUSA, M.D.Centrilobular Hepatic Necrosis in Cardiac Failure 1 May 1962Volume 56, Issue 5_Part_1Page: 784-788KeywordsAminotransferasesHeart failureHepatitis AHepatitis E virusHypotensionLesionsLiverNecrosisResearch laboratoriesStenosis ePublished: 1 December 2008 Issue Published: 1 May 1962 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Robert G. Logan (1962) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: